Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$1.62M Buy
27,501
+4,122
+18% +$236K 0.24% 133
2014
Q4
$1.25M Sell
23,379
-14,631
-38% -$819K 0.19% 159
2014
Q3
$2.2M Buy
38,010
+4,578
+14% +$281K 0.35% 87
2014
Q2
$2.23M Buy
33,432
+6,235
+23% +$422K 0.37% 84
2014
Q1
$1.82M Buy
27,197
+13,131
+93% +$888K 0.36% 89
2013
Q4
$939K Buy
14,066
+10,268
+270% +$666K 0.31% 84
2013
Q3
$238K Hold
3,798
0.09% 221
2013
Q2
$237K Buy
+3,798
New +$241K 0.08% 222

Other funds holding GSK

Sterne Agee Group's GSK Position: Q1 2015 in Review

Sterne Agee Group increased its GSK (GSK) stake by 18% in Q1 2015, buying an estimated $236K and bringing the position to 27,501 shares worth $1.62M. The position accounts for 0.24% of the portfolio, ranked #133.

Sterne Agee Group first reported a position in GSK in Q2 2013 and has held it in 8 quarters since. The position peaked at $2.23M in Q2 2014. 740 funds tracked by Wall St. Rank hold GSK as of Q1 2015.

  • Sterne Agee Group held 27,501 shares of GSK worth $1.62M as of Q1 2015.
  • Sterne Agee Group bought 4,122 GSK shares in Q1 2015, an estimated $236K.
  • GSK made up 0.24% of Sterne Agee Group's portfolio in Q1 2015, its #133 holding.
  • Sterne Agee Group first reported a position in GSK in Q2 2013 and has held it in 8 quarters since.
  • Sterne Agee Group's GSK position peaked at $2.23M in Q2 2014.
  • 740 funds tracked by Wall St. Rank held GSK as of Q1 2015.

Based on Sterne Agee Group's 13F filing for Q1 2015, filed 13 May 2015.